Insulin-like growth factor binding protein-5 proteolytic activity in ovine articular chondrocyte culture

Biochimica et Biophysica Acta - General Subjects

Volumn 1425, Issue 3, 1998, Pages 567-576

  Sunic, Damir ^a,b   McNeil, Julian D ^a   Andress, Dennis L ^c   Belford, David A ^b  

^a MODBURY HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Articular chondrocyte; Insulin like growth factor binding protein 5; Insulin like growth factor I; Interleukin 1; Protease inhibitor; Proteolysis

Indexed keywords

APROTININ; HEPARIN; INTERLEUKIN 1; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SHEEP;

EID: 0031788406     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(98)00110-X     Document Type: Article

References (31)

1. D.J. McQuillan, C.J. Handley, M.A. Campbell, S. Bolis, V.E. Milway, A.C. Herington, Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage, Biochem. J. 240 (1986) 423-430.
2. J. Schalkwijk, L.A. Joosten, W.B. van den Berg, J.J. van Wyk, L.B. van de Putte, Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid, Arthritis Rheum. 32 (1989) 66-71.
3. D.R. Clemmons, IGF binding proteins and their functions, Mol. Reprod. Dev. 35 (1993) 368-374.
4. S. Shimasaki, N. Ling, Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6), Prog. Growth Factor Res. 3 (1991) 243-266.
5. Y. Oh, S.R. Nagalla, Y. Yamanaka, H.-S. Kim, E. Wilson, R.G. Rosenfeld, Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7, J. Biol. Chem. 271 (1996) 30322-30325.
6. B. Froger Gaillard, P. Hossenlopp, M. Adolphe, M. Binoux, Production of insulin-like growth factors and their binding proteins by rabbit articular chondrocytes: relationships with cell multiplication, Endocrinology 124 (1989) 2365-2372.
7. W.M. Burch, J. Correa, J.E. Shively, D.R. Powell, The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro, J. Clin. Endocrinol. Metab. 70 (1990) 173-180.
8. R.C. Olney, R.L. Smith, Y. Kee, D.M. Wilson, Production and hormonal regulation of insulin-like growth factor binding proteins in bovine chondrocytes, Endocrinology 133 (1993) 563-570.
9. D. Sunic, D.A. Belford, J.D. McNeil, O.W. Wiebkin, Insulin-like growth factor binding proteins (IGF-BPs) in bovine articular and ovine growth-plate chondrocyte cultures - their regulation by IGFs and modulation of proteoglycan synthesis, Biochim. Biophys. Acta 1245 (1995) 43-48.
10. T. Matsumoto, S.E. Gargosky, Y. Oh, R.G. Rosenfeld, Transcriptional and post-translational regulation of insulin-like growth factor-binding protein-5 in rat articular chondrocytes, J. Endocrinol. 148 (1996) 355-369.
11. D. Sunic, J.D. McNeil, T.E. Rayner, D.L. Andress, D.A. Belford, Regulation of insulin-like growth factor binding protein-5 by insulin-like growth factor-I and interleukin-1α in ovine articular chondrocytes, Endocrinology 139 (1998) 2356-2362.
12. S. Kanzaki, S. Hilliker, D.J. Baylink, S. Mohan, Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases, Endocrinology 134 (1994) 383-392.
13. T.J. Nam, W.H. Busby Jr., D.R. Clemmons, Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5, Endocrinology 135 (1994) 1385-1391.
14. J.L. Fowlkes, J.J. Enghild, K. Suzuki, H. Nagase, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures, J. Biol. Chem. 269 (1994) 25742-25746.
15. K.M. Thrailkill, L.D. Quarles, H. Nagase, K. Suzuki, D.M. Serra, J.L. Fowlkes, Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation, Endocrinology 136 (1995) 3527-3533.
16. T. Matsumoto, S.E. Gargosky, K. Kelley, R.G. Rosenfeld, Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line, Growth Regul. 6 (1996) 185-190.
17. D.L. Andress, Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells, J. Biol. Chem. 270 (1995) 28289-28296.
18. E. Van Obberghen Schilling, J. Pouyssegur, Mitogen-potentiating action and binding characteristics of insulin and insulin-like growth factors in Chinese hamster fibroblasts, Exp. Cell Res. 147 (1983) 369-378.
19. P. Hossenlopp, D. Seurin, B. Segovia Quinson, S. Hardouin, M. Binoux, Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies, Anal. Biochem. 154 (1986) 138-143.
20. T. Arai, A. Arai, W.H. Busby, D.R. Clemmons, Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5, Endocrinology 135 (1994) 2358-2363.
21. A. Parker, A. Gockerman, W.H. Busby, D.R. Clemmons, Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells, Endocrinology 136 (1995) 2470-2476.
22. T. Arai, J. Clarke, A. Parker, W. Busby Jr., T. Nam, D.R. Clemmons, Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin, J. Biol. Chem. 271 (1996) 6099-6106.
23. A. Parker, J.B. Clarke, W.H. Busby Jr., D.R. Clemmons, Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5, J. Biol. Chem. 271 (1996) 13523-13529.
24. P.G. Campbell, D.L. Andress, Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218), Am. J. Physiol. 273 (1997) E996-E1004.
25. R.W. Grimes, J.M. Hammond, Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I, Endocrinology 134 (1994) 337-343.
26. P.J. Fielder, H. Pham, E.Y. Adashi, R.G. Rosenfeld, Insulin-like growth factors (IGFs) block FSH-induced proteolysis of IGF-binding protein-5 (BP-5) in cultured rat granulosa cells, Endocrinology 133 (1993) 415-418.
27. P. Cohen, D.M. Peehl, H.C. Graves, R.G. Rosenfeld, Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease, J. Endocrinol. 142 (1994) 407-415.
28. S.D. Chernausek, C.E. Smith, K.L. Duffin, W.H. Busby, G. Wright, D.R. Clemmons, Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4, J. Biol. Chem. 270 (1995) 11377-11382.
29. C.A. Conover, S.K. Durham, J. Zapf, F.R. Masiarz, M.C. Kiefer, Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants, J. Biol. Chem. 270 (1995) 4395-4400.
30. D.L. Andress, S.M. Loop, J. Zapf, M.C. Kiefer, Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells, Biochem. Biophys. Res. Commun. 195 (1993) 25-30.
31. Y. Imai, W.H. Busby Jr., C.E. Smith, J.B. Clarke, A.J. Garmong, G.D. Horwitz, C. Rees, D.R. Clemmons, Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture, J. Clin. Invest. 100 (1997) 2596-2605.